Navigation Links
St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection

amivir, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates, that our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future clinical trials may not have positive results, that we may not be able to complete successfully the Phase IIb trial for Fodosine(TM) that is currently planned to be pivotal, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that BioCryst may not reach favorable agreements with potential pharmaceutical and biotech partners for further development of its product candidates, that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K which identify important factors that could cause the actual results to differ materially from those contained in the projections or forward-looking statements.

    Contact:

    BioCryst Pharmaceuticals, Inc.

    Jonathan M. Nugent

    V.P. Corporate Communications

    (205) 444-4633

CONTACT: Jonathan M. Nugent, V.P. Corporate Communications of BioCrystPharmaceuticals, Inc., +1-205-444-4633

Web site: http://www.biocryst.com/'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/2/2015)... , July 3, 2015 ... adquisición del 100% de participación en ZAO "Biocom" ... adquisición marca la incursión de Lupin en el ... de RUB en ventas, colocándolo como uno de ... 2014 (IMS Health). Durante más de una década, ...
(Date:7/2/2015)... N.C. , July 2, 2015  New product ... of its leading role in educating thought leaders about ... that can heavily influence how well a new therapy ... new study from research and consulting leader Best Practices, ... leaders need to focus on are early stage thought ...
(Date:7/2/2015)... -- According to a new market research report ... Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, ... by MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 ... by 2020, at a CAGR of 11.2% during the forecast ... market data T ables and ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
... Rescue Riders, a national volunteer organization dedicated to giving ... has selected the HeartSine® samaritan® PAD Automated External Defibrillator (AED) for ... , , ... in 40 states who are trained as first responders for roadside ...
... , , , ... 3 Recently, researchers have observed a disturbing trend in neonatal units across ... to treat premature infants. This alarming development has raised serious concerns from many consumer ... , , ...
Cached Medicine Technology:Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs 2Spike in Use of Popular Reflux Drug to Treat Infants Causes Alarm 2
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . To be held from March 4th - 6th, the 2016 (a previous ... Galleria Dallas. , Designed to take participants from the basic training and fundamentals of ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the ... to lead a national chief nursing officer recruitment for Jane Phillips ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... ... , ... Smoothies are all the rage right now and all you need ... Aurora Natural is proud to introduce a new line of all natural products that ... and minerals! , Aurora is offering a variety of blends and stand-alone items to ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Jennifer Renee Hanes, ... Choice Emergency Room , the largest network of independent freestanding emergency rooms in the ... medical director of our Sienna Plantation facility,” said Executive Medical Director of First Choice ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... prevent early tooth decay, damage , SATURDAY, March 6 (HealthDay ... a healthy start is to begin dental care early in ... kids, teeth in tip-top shape: , Visit the dentist ... of the eruption of a child,s first tooth, but no ...
... Dr. Christine Petti, ... to the community with an Evening of Beauty on Tuesday, March 9th. The event will feature ... successful procedures, as well as a demonstration of a new skin rejuvenation treatment and offers of ... (Vocus) March 6, 2010 ...
... ... her award-winning cloth diapers, she did not have to look very far from home. Not ... her company to support its community , ... Calgary, Alberta, Canada (PRWEB) March 6, 2010 -- When Calgary-based Ecobumz Diapers owner ...
... ... ... , ... Eight-Year Childhood Obesity Prevention Program Reflects First Lady,s Focus , ...
... dent in the problem, researcher says , FRIDAY, March 5 ... 130,000 new cases of diabetes, 14,000 new cases of heart ... the last decade, a new U.S. study finds. , "The ... might have a dramatic health benefit," said senior study author ...
... ... ... ... ...
Cached Medicine News:Health News:Protect Your Baby's Smile 2Health News:Los Angeles Plastic Surgeon Christine Petti, MD Gives Patients an Evening of Beauty 2Health News:Los Angeles Plastic Surgeon Christine Petti, MD Gives Patients an Evening of Beauty 3Health News:Ecobumz Diapers are Going Green While Investing in its Own Community and Employing Women Looking to Enter or Re-enter the Workplace 2Health News:KID HEALTHY-Steps to Healthy Living Kicks Off 2010 Campaign to Make Southern California Kids and Families Healthier 2Health News:KID HEALTHY-Steps to Healthy Living Kicks Off 2010 Campaign to Make Southern California Kids and Families Healthier 3Health News:Increasing Soda Consumption Fuels Rise in Diabetes, Heart Disease 2Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 4Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 5
... Stand Magnifier offers versatility across a ... lens and the light are adjustable. ... hand held objects can be worked ... parallel to the work surface, lay ...
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Piston assembly fits into neck of platform ... ready position after use. Cutting block fits ... disposable trephine blades sized 6.25 - 9.0 ... the preparation of corneal donor buttons for ...
... allows the surgeon to effectively ... scrub-resistant, gentian violet ink. All ... sterile, with a ruler and ... pouches. Micro tip marker for ...
Medicine Products: